As of Apr 29
| -0.05 / -2.92%|
The 3 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +201.20% increase from the last price of 1.66.
The current consensus among 4 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.